---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-048910"
form_type: "8-K"
ticker: "INTS"
cik: "0001567264"
company_name: "INTENSITY THERAPEUTICS, INC."
filed_at: "2024-11-22T23:59:59+00:00"
generated_at: "2026-05-29T19:44:34.209665+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Intensity Therapeutics prices $3M registered direct offering and warrants

## Summary
- Sold 1,237,113 shares at $2.425/share for gross proceeds of ~$3M.
- Issued warrants for up to 1,237,113 shares at $2.95, exercisable after 6 months, 5.5-year term.
- Closing expected Nov 22, 2024; net proceeds for general working capital.
- A.G.P./Alliance Global Partners lead placement agent; Brookline Capital Markets co-agent.

## SEC filing metadata
- accession: 0001628280-24-048910
- form_type: 8-K
- ticker: INTS
- cik: 0001567264
- company_name: INTENSITY THERAPEUTICS, INC.
- filed_at: 2024-11-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1567264/000162828024048910/0001628280-24-048910-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1567264/000162828024048910/intensity-20241121.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-048910
- JSON: https://secwatch.observer/filing/0001628280-24-048910.json
- Plain text: https://secwatch.observer/filing/0001628280-24-048910.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.